Följ
Paul B Finn
Paul B Finn
Co-Founder, Enoda
Verifierad e-postadress på enoda.bio - Startsida
Titel
Citeras av
Citeras av
År
Advances in CRISPR therapeutics
M Chavez, X Chen, PB Finn, LS Qi
Nature Reviews Nephrology, 2022
1122022
Carbocyclic Amino Ketones by Bredt's Rule‐Arrested Kulinkovich–de Meijere Reaction
PB Finn, BP Derstine, SMN Sieburth
Angewandte Chemie 128 (7), 2582-2585, 2016
112016
Single position substitution of hairpin pyrrole-imidazole polyamides imparts distinct DNA-binding profiles across the human genome
PB Finn, D Bhimsaria, A Ali, A Eguchi, AZ Ansari, PB Dervan
Plos one 15 (12), e0243905, 2020
102020
Molecular Recognition of DNA by Py–Im Polyamides: From Discovery to Oncology
PB Dervan, AA Kurmis, PB Finn
DNA-targeting Molecules as Therapeutic Agents, 298 – 331, 2018
92018
Formation and isomerization of polycyclic 1, 5-enynes
PB Finn, S Kulyk, SMN Sieburth
Tetrahedron Letters 56 (23), 3567-3570, 2015
72015
Programmable Drug Control of Receptor Valency Modulates the Potency of Cell Therapeutics
LSQ PB Finn, M Chavez, X Chen, H Wang, DA Rane, J Gurjar
BioRxiv, 2023
22023
Alpha-amino silanes via metalated imines as an approach to the synthesis of silanediol protease inhibitors
Y Bo, PB Finn, BB Khatri, SMN Sieburth
Tetrahedron 69 (36), 7779-7784, 2013
22013
COMPOSITION AND METHOD OF VALENCY CONTROLLED RECEPTOR SYSTEMS FOR CELL ENGINEERING AND THERAPY
LS Qi, PB Finn
US Patent App. 18/704,007, 2025
2025
Synthetic oligomerization systems for cell engineering and therapy
LS Qi, M Chavez, PB Finn
US Patent App. 18/007,283, 2024
2024
Drug-Mediated Control of Receptor Valency Enhances Immune Cell Potency
P Finn, M Chavez, X Chen, H Wang, DA Rane, J Gurjar, LS Qi
bioRxiv, 2023
2023
Synthetic oligomerization systems for cell engineering and therapy
PBF Lei S. Qi, Michael Chavez
WO Patent WO2022026618A2, 2022
2022
Photochemical and titanium-mediated methods for synthesis of molecular scaffolds
PB Finn
Temple University, 2015
2015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–12